{
    "organizations": [],
    "uuid": "834101363a33b8839554be0d97dd7df7641ce43f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-on-target-laboratories-says-first/brief-on-target-laboratories-says-first-patient-treated-in-key-ovarian-cancer-trial-idUSASC09V0W",
    "ord_in_thread": 0,
    "title": "BRIEF-On Target Laboratories Says First Patient Treated In Key Ovarian Cancer Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - On Target Laboratories:\n* FIRST PATIENT TREATED IN PIVOTAL PHASE 3 TRIAL TO EVALUATE OTL38 IN THE DETECTION OF OVARIAN CANCER Source text for Eikon:\n ",
    "published": "2018-04-05T20:18:00.000+03:00",
    "crawled": "2018-04-06T21:59:18.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "target",
        "laboratory",
        "first",
        "patient",
        "treated",
        "pivotal",
        "phase",
        "trial",
        "evaluate",
        "otl38",
        "detection",
        "ovarian",
        "cancer",
        "source",
        "text",
        "eikon"
    ]
}